Judith Spijkerman

Effects of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugate Vaccine on Nasopharyngeal Bacterial Colonization in Young Children: A Randomized Controlled Trial

Menno R. van den Bergh, Judith Spijkerman, Kristien Swinnen et al. · Clinical Infectious Diseases · 2012 · 133 citations · Full text

Carriage of<i>Streptococcus pneumoniae</i>3 Years after Start of Vaccination Program, the Netherlands

Judith Spijkerman, Elske J. M. van Gils, Reinier H. Veenhoven et al. · Emerging infectious diseases · 2011 · 89 citations · Full text

Carriage of<i>Streptococcus pneumoniae</i>3 Years after Start of Vaccination Program, the Netherlands

Judith Spijkerman, Elske J. M. van Gils, Reinier H. Veenhoven et al. · Emerging infectious diseases · 2011 · 85 citations · Full text

Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine Administered According to 4 Different Primary Immunization Schedules in Infants

Judith Spijkerman, Reinier H. Veenhoven, Alienke J. Wijmenga‐Monsuur et al. · JAMA · 2013 · 77 citations

Immunogenicity, Safety, and Reactogenicity of the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine and DTPa-IPV-Hib When Coadministered as a 3-dose Primary Vaccination Schedule in the Netherlands

Menno R. van den Bergh, Judith Spijkerman, Nancy François et al. · The Pediatric Infectious Disease Journal · 2011 · 42 citations